The short answer
Tumor ablation destroys a tumor in place through a needle-sized probe guided by ultrasound, CT, or MRI. NCI's liver PDQ reports that radiofrequency ablation does best in tumors under 3 cm, with 5-year overall survival as high as 59%. NCI's renal cell PDQ lists cryotherapy and thermal ablation among stage I kidney cancer options.
NCI's liver PDQ sorts ablation by mechanism: temperature change (RFA, microwave, cryoablation), a chemical (percutaneous ethanol injection), or direct membrane damage (electroporation).
The 3 cm figure comes from outcome data: PDQ says RFA achieves its best results below 3 cm, with 5-year overall survival as high as 59%, and local control falling off steadily above that size.
PDQ calls ablation relatively contraindicated near bile ducts, the diaphragm, and other abdominal organs, and describes the heat-sink effect near major vessels, where flowing blood carries heat away.
RadiologyInfo puts each ablation at 10 to 30 minutes and the whole procedure at one to three hours, with no stitches and return to usual activities in one to seven days.
Choose how you want to understand this
The full explanation.
Destroying a tumor without removing it
Ablation kills a tumor where it sits. No specimen is taken out. A doctor threads a needle-sized probe to the tumor and delivers energy that destroys the cells.
RadiologyInfo.org describes the guidance step. Ultrasound, CT, or MRI steers the probe. An interventional radiologist usually does the work. The setting is a radiology suite, or sometimes an operating room.
NCI's PDQ summary on primary liver cancer sorts ablation by what kills the cells. One route is a change in temperature. That covers RFA, or radiofrequency ablation, plus microwave and cryoablation. A second route is a chemical. That is PEI, or percutaneous ethanol injection, which is an alcohol shot into the tumor. A third route damages the cell membrane directly, by electroporation.
The three energy sources
RFA passes a current through tissue to heat it until cells die. NCI's liver summary calls RFA a well-established technique for liver cancer.
Microwave ablation (MWA) heats tissue with microwave energy. PDQ lists it beside RFA as a temperature-based method.
Cryoablation freezes instead. NCI's cryosurgery fact sheet says the cold comes from liquid nitrogen or argon gas flowing through a cryoprobe. More than one probe may be used to freeze different parts of a tumor. When frozen tissue thaws, the cells die. Inside the body, that dead tissue is absorbed. On the skin, it forms a scab that falls off.
RadiologyInfo states plainly that for many tumor types there are no known differences between heat-based and cold-based treatment. Claims that one is gentler are not supported there.
Where 3 centimeters comes from
The size limit people hear about is not a rule of thumb. It comes from outcome data.
NCI's liver PDQ reports that RFA does best in tumors under 3 cm. In that group, 5-year overall survival may reach 59%. Recurrence-free survival may not differ much from surgery. Above 3 cm, PDQ says local control drops off steadily.
PEI has its own bracket. It applies to a single tumor under 3 cm in Child-Pugh class A cirrhosis, the mildest grade of liver damage. There, PDQ puts 5-year overall survival at 40% to 59%.
Head to head, PDQ says randomized trials in Child-Pugh class A cirrhosis favored RFA. RFA beat PEI on complete response and on local return. Some trials also showed better survival. RFA needs fewer sessions too. PDQ notes RFA may carry more complications than PEI. But it says both have fewer complications than cutting the tumor out.
Two reasons a tumor may be a poor target
PDQ names anatomic limits that decide the answer more than size does.
PDQ calls ablation relatively contraindicated near bile ducts. The same goes for the diaphragm. It also goes for other belly organs the probe could injure.
Then there is the heat-sink effect. When a tumor sits beside a major blood vessel, flowing blood carries heat away. PDQ says thermal methods such as RFA may never reach the temperature needed, which can prevent complete tumor destruction.
RadiologyInfo adds a third limit. Tumors under 2 to 3 mm often cannot be seen on scans. What cannot be seen cannot be targeted. Ablation is also local. It treats one site.
Where it fits in liver and kidney care
For liver cancer, PDQ positions ablation for when removal by transplant or resection is not feasible or advisable. It calls ablation useful for early hepatocellular carcinoma sitting deep in the liver. Cutting there would cost too much working liver tissue.
NCI's renal cell PDQ lists ablation for stage I kidney cancer. Its option list runs: partial nephrectomy, radical nephrectomy, simple nephrectomy, cryotherapy, thermal ablation, stereotactic radiation, and trials. PDQ calls cryoablation, thermal ablation, and stereotactic radiation curative choices. They are for people who cannot have the tumor cut out.
NCI's cryosurgery fact sheet reaches further. Its list runs long. Retinoblastoma, an eye cancer of childhood. Basal cell and squamous cell skin cancers. Skin lesions from AIDS-related Kaposi sarcoma. Early-stage prostate cancer. Liver cancer that has stayed in the liver. Bone cancer, mostly chondrosarcoma. And non-small cell lung cancer.
What the day itself looks like
RadiologyInfo gives concrete timings. Each ablation takes about 10 to 30 minutes. The whole visit usually runs one to three hours, longer when a large tumor needs the probe repositioned or several probes placed.
Monitors track heart rate, blood pressure, oxygen, and pulse. An IV line delivers a sedative. The skin over the target is cleaned, draped, and numbed. Some cases add deeper sedation or general anesthesia. That choice is made at the first visit.
At the end the probe comes out, pressure stops any bleeding, and a dressing goes on. No stitches are needed. Most ablation is outpatient, though an overnight stay for observation is sometimes needed.
Recovery, in numbers
RadiologyInfo puts return to usual activities at one to seven days, with no heavy lifting for at least 72 hours. About 10% of patients still have pain a week later.
Fever is common enough to expect rather than fear. About one-third develop fever and flu-like symptoms within days, which RadiologyInfo says often clears within 10 days. It also describes post-ablation syndrome in roughly 1 in 4 patients. Flu-like symptoms start 3 to 5 days out. They usually last about 5 days. Now and then they run two to three weeks. RadiologyInfo names acetaminophen or ibuprofen for managing them.
Infection serious enough to need antibiotics appears to run under 1 in 1,000, per RadiologyInfo. Bleeding and injury to nearby structures are also listed.
Neither RadiologyInfo nor NCI's cryosurgery page publishes a temperature cutoff for calling the team after ablation. That number has to come from the discharge sheet for the exact procedure. It is worth asking for before leaving.
Following up
RadiologyInfo says the interventional radiologist sends a signed report to the referring doctor. Follow-up may include a physical check, imaging, and blood tests. Imaging matters here. An untreated rim at the tumor edge can require a second session.
Ablation sits alongside other local options. The specialty behind it is described in interventional radiology in cancer care. Trade-offs against an operation are covered in surgery for cancer. The radiation choice NCI lists for stage I kidney tumors is weighed in SBRT vs. surgery.
When to get help sooner
Your own temperature cutoff has to come from the discharge sheet for the exact procedure, since neither source above publishes one. Ask for it before you leave.
- Call 911 or go to an emergency department if severe belly, chest or shoulder pain comes on suddenly, or you feel faint, or you cough up or pass blood. Bleeding and injury to nearby structures are listed complications.
- Call your care team the same day if fever or chills arrive alongside pain that is worsening rather than easing, or the puncture site turns red, hot, or starts oozing. Infection needing antibiotics is rare, under 1 in 1,000, and is treated quickly.
- Call your care team within a day or two if flu-like symptoms are still going beyond about 10 days, or pain is unchanged a week on, or a fever keeps returning after the first few days.
Sources
Words to know
Tap any term to see what it means.

Common questions
What is tumor ablation?
A procedure that destroys a tumor where it sits rather than removing it. RadiologyInfo describes an interventional radiologist advancing a needle probe under ultrasound, CT, or MRI guidance, then activating it to heat or freeze the tumor. NCI's liver PDQ groups the methods by what kills the cells: temperature change, a chemical such as ethanol, or direct damage to the cell membrane.
What is the difference between RFA, microwave ablation, and cryoablation?
RFA and microwave ablation both destroy tissue with heat; cryoablation freezes it. NCI's cryosurgery fact sheet says the cold comes from liquid nitrogen or argon gas circulating through a cryoprobe, and that more than one probe may be used on a single tumor. RadiologyInfo states that for many tumor types there are no known differences between heat-based and cold-based treatment.
Why do doctors talk about 3 centimeters?
Because that is where the outcome data changes. NCI's liver PDQ says RFA achieves its best results in tumors smaller than 3 cm, where 5-year overall survival may reach 59% and recurrence-free survival may not differ much from surgical resection. Above 3 cm, PDQ says local control progressively diminishes as the tumor grows.
What makes a tumor a poor target for ablation?
PDQ lists proximity to bile ducts, the diaphragm, or other intra-abdominal organs as relative contraindications. It also describes the heat-sink effect: near a major blood vessel, flowing blood carries heat away, so thermal methods may not reach the temperature needed for complete tumor necrosis. RadiologyInfo adds that tumors under 2 to 3 mm often cannot be seen on imaging, and what cannot be seen cannot be ablated.
What is recovery like?
RadiologyInfo says most people resume usual activities within one to seven days and should avoid heavy lifting for at least 72 hours. About 10% still have pain a week later. About one-third develop fever and flu-like symptoms within days, usually resolving within 10 days, and about 1 in 4 develop post-ablation syndrome starting 3 to 5 days afterward and lasting about 5 days.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-11Next planned review: 2027-02-03
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
